Race Oncology Past Earnings Performance

Past criteria checks 0/6

Race Oncology's earnings have been declining at an average annual rate of -27.6%, while the Biotechs industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 64.9% per year.

Key information

-27.6%

Earnings growth rate

-16.3%

EPS growth rate

Biotechs Industry Growth9.6%
Revenue growth rate64.9%
Return on equity-75.5%
Net Margin-345.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Is Race Oncology (ASX:RAC) In A Good Position To Deliver On Growth Plans?

Aug 26
Is Race Oncology (ASX:RAC) In A Good Position To Deliver On Growth Plans?

We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

May 10
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Jan 23
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

Jun 20
Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Feb 17
We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 14
Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Apr 01
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

Apr 05
We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

Mar 01
What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Jan 07
How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Revenue & Expenses Breakdown

How Race Oncology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:RAC Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244-14411
31 Mar 245-12411
31 Dec 236-11311
30 Sep 234-1139
30 Jun 233-1038
31 Mar 232-1037
31 Dec 221-1137
30 Sep 221-1146
30 Jun 221-1146
31 Mar 221-1045
31 Dec 211-944
30 Sep 211-843
30 Jun 210-632
31 Mar 210-532
31 Dec 200-431
30 Sep 200-421
30 Jun 200-421
31 Mar 200-321
31 Dec 190-311
30 Sep 190-311
30 Jun 190-421
31 Mar 190-421
31 Dec 180-531
30 Sep 180-641
30 Jun 180-641
31 Mar 180-641
31 Dec 170-631
30 Sep 170-531
30 Jun 170-431
31 Mar 170-321
31 Dec 160-220
30 Sep 160-110
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150000
30 Jun 150000

Quality Earnings: RAC is currently unprofitable.

Growing Profit Margin: RAC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RAC is unprofitable, and losses have increased over the past 5 years at a rate of 27.6% per year.

Accelerating Growth: Unable to compare RAC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RAC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.6%).


Return on Equity

High ROE: RAC has a negative Return on Equity (-75.47%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies